Education
About Us
Working with TipRanks
Follow Us
The United Laboratories International Holdings Limited (ULIHF)
OTHER OTC:ULIHF
RESEARCH TOOLSreports
Total Valuation
The United Laboratories International Holdings has a market cap or net worth of $3.12B. The enterprise value is $9.80B.
Market Cap$3.12B
Enterprise Value$9.80B
Share Statistics
The United Laboratories International Holdings has 1.82B shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1.82B
Owned by Insiders
Owned by Instutions0.09%
Financial Efficiency
The United Laboratories International Holdings’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 18.21%.
Return on Equity (ROE)21.21%
Return on Assets (ROA)12.85%
Return on Invested Capital (ROIC)18.21%
Return on Capital Employed (ROCE)22.86%
Revenue Per Employee$824,068.176
Profits Per Employee$171,074
Employee Count17,000
Asset Turnover0.65
Inventory Turnover3.31
Valuation Ratios
The current PE Ratio of The United Laboratories International Holdings is 4.38. The United Laboratories International Holdings’s PEG ratio is 0.06.
PE Ratio4.38
PS Ratio0.86
PB Ratio0.93
Price to Fair Value0.93
Price to FCF12.11
Price to Operating Cash Flow4.85
PEG Ratio0.06
Income Statement
In the last 12 months, The United Laboratories International Holdings had revenue of $14.01B and earned $2.91B in profits. Earnings per share was $1.60.
Revenue$14.01B
Gross Profit$6.47B
Operating Income$3.48B
Pretax Income$3.63B
Net Income$2.91B
EBITDA3.92B
Earnings Per Share (EPS)1.60
Cash Flow
In the last 12 months, operating cash flow was $3.09B and capital expenditures -$1.58B, giving a free cash flow of $1.50B billion.
Operating Cash Flow$3.09B
Free Cash Flow$1.50B
Free Cash Flow per Share$0.83
Dividends & Yields
The United Laboratories International Holdings pays an annual dividend of $0.02, resulting in a dividend yield of 5.52%
Dividend Per Share$0.02
Dividend Yield5.52%
Payout Ratio19.89%
Free Cash Flow Yield8.26%
Earnings Yield22.82%
Stock Price Statistics
Beta-0.41
52-Week Price Change16.39%
50-Day Moving Average1.71
200-Day Moving Average1.39
Relative Strength Index (RSI)32.46
Average Volume (3m)3.49K
Important Dates
The United Laboratories International Holdings upcoming earnings date is Aug 21, 2025, TBA.
Last Earnings DateMar 25, 2025
Next Earnings DateAug 21, 2025
Ex-Dividend DateJul 8, 2025
Financial Position
The United Laboratories International Holdings as a current ratio of 2.08, with Debt / Equity ratio of 0.12
Current Ratio2.08
Quick Ratio1.74
Debt to Market Cap0.13
Net Debt to EBITDA-0.69
Interest Coverage Ratio49.17
Taxes
In the past 12 months, The United Laboratories International Holdings has paid $726.10M in taxes.
Income Tax$726.10M
Effective Tax Rate19.24%
Enterprise Valuation
The United Laboratories International Holdings EV to EBITDA ratio is 2.28, with an EV/FCF ratio of 9.29.
EV to Sales0.66
EV to EBITDA2.28
EV to Free Cash Flow9.29
EV to Operating Cash Flow3.72
Balance Sheet
The United Laboratories International Holdings has $6.55B in cash and marketable securities with $2.46B in debt, giving a net cash position of -$4.10B billion.
Cash & Marketable Securities$6.55B
Total Debt$2.46B
Net Cash-$4.10B
Net Cash Per Share-$2.26
Tangible Book Value Per Share$7.01
Margins
Gross margin is 46.11%, with operating margin of 23.94%, and net profit margin of 19.66%.
Gross Margin46.11%
Operating Margin23.94%
Pretax Margin24.34%
Net Profit Margin19.66%
EBITDA Margin28.94%
EBIT Margin24.83%
Analyst Forecast
The average price target for The United Laboratories International Holdings is $2.08, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$2.08
Price Target Upside46.48%
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast
EPS Growth Forecast